Sobre 3 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Browse the full record of transactions filed by Ragosa Mark, Director Financiero. Officer active across 2 companies, notably Kiniksa Pharmaceuticals, Ltd.. Cumulatively, 36 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €430k. Activity tracked since 3 January 2024. The latest transaction was disclosed on 7 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Ragosa Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
991 títulosClass A Common ShareSEC:0001415889-24-011764:0
25 de 36 declaraciones
About Ragosa Mark
Mark Ragosa is the Chief Financial Officer of Kiniksa Pharmaceuticals, Ltd. In this role, he oversees the company's financial management, including financial planning and investment strategy. His expertise is crucial for Kiniksa's growth and financial viability.